Amarantus Bioscience Holdings Inc (AMBS)

[gz69]

I share your view.

The other option is that LymPro is licensed by Becton Dickinson and the share price moves above $1.00 and then Amgen enters into a license agreement to develop MANF and the share price moves over $5.00.

This doesn't happen to thousands of companies but it may well happen to "$AMBS".

I a bit of a history buff and therefore goes back and watch previous video clips of AMBS. The January OneMedForumSF 2013 was worth watching closely. This was a detailed scientific presentation.

I have no doubt the business strategies are brilliant...play out several fishing lines and get the revenue from Lympro and finance MANF.

There is no hype nor high pitch salesmanship in Gerald in all his video interviews and presentations. A quiet assertion on what he and his father firmly believe in. The challenges are there for sure but I see the commitment and the passion. I vote with my wallet.